AIRS Market Analysis

Overview

Fundamentals

P/E ratio
EPS (TTM)$-0.19200.0% YoY
Profit margin-7.7%HEALTHCARE
Market cap$234.2MMicro cap

Wall Street coverage

$3.00median target· current $5.60 (-46.4%)2 analysts

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

Valuation

Forward P/E
PEG ratio
P/B
2.67
P/S (TTM)
1.54
EV/EBITDA
253.34

Profitability & growth

ROE (TTM)
-14.1%
Operating margin
-4.6%
Revenue growth YoY
-14.6%
Dividend yield
Beta
2.02
Last earnings
Mar 6, 2026 · Estimate $-0.03 · Reported $-0.02
Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

News & Sentiment

Page 1 of 3 · 50 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

About Airsculpt Technologies Inc

Airsculpt Technologies Inc (AIRS) is a leader in the aesthetic medical technology field, recognized for its proprietary AirSculpt® procedure, which offers minimally invasive body contouring solutions while emphasizing patient safety and comfort. The company boasts a growing network of licensed practitioners and a strong focus on technological innovation, positioning itself advantageously in the expanding market for non-invasive cosmetic treatments. By responding to the rising global demand for aesthetic procedures, Airsculpt aims to enhance its market share and diversify its service…

Classification

Exchange
NASDAQ
Country
USA
Currency
USD

Company profile

HQ
1111 LINCOLN ROAD, MIAMI BEACH, FL
Fiscal year end
December
Latest quarter
Dec 31, 2025
Market cap$234.2M
Shares outstanding$70.5M
52W high$12.00
52W low$1.51

Educational content · Not investment advice or recommendations

We're educators, not advisors. Your decisions are your own. Disclaimer